Correlation Between Insulet and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both Insulet and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Insulet and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Insulet and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Insulet and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Insulet with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Insulet and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Insulet and SCANDMEDICAL SOLDK-040

-0.18

Correlation Coefficient

Insulet  SCANDMEDICAL SOLDK-040

Good diversification

The 3 months correlation between Insulet and SCANDMEDICAL is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Insulet and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Insulet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Insulet are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Insulet i.e., Insulet and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Insulet and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Insulet is expected to generate 0.65 times more return on investment than SCANDMEDICAL SOLDK-040. However, Insulet is 1.55 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.29 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about 0.0 per unit of risk. If you would invest  18,155  in Insulet on August 31, 2024 and sell it today you would earn a total of  6,965  from holding Insulet or generate 38.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Insulet  vs.  SCANDMEDICAL SOLDK 040

Insulet

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Insulet are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Insulet reported solid returns over the last few months and may actually be approaching a breakup point.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Insulet and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Insulet and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Insulet position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind Insulet and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.